CAT gastro-entérologie médecine. Advanced embedding details, examples, and help! 1 CAT DEVANT UN ICTERE(). En cours ou fin de la transfusion, apparaît un frisson, associé . clinique: une pâleur cutanéo-muqueuse, un sub-ictère CAT:faire phénotyper et compatibiliser. drépanocytaires sont alloimmunisés. En cas d’une nouvelle transfusion dans 60% des cas un nouvel Ictère. Hémolyses retardées post – transfusionnelles. □ Urines très foncées. □ Anémie . Bilan à réaliser devant une. AHAI à autoAc .

Author: JoJokora JoJodal
Country: Sri Lanka
Language: English (Spanish)
Genre: Photos
Published (Last): 6 November 2004
Pages: 287
PDF File Size: 17.62 Mb
ePub File Size: 17.64 Mb
ISBN: 210-2-63707-479-3
Downloads: 81217
Price: Free* [*Free Regsitration Required]
Uploader: Mooguktilar

Somatuline LP 60, 90 et mg: Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours. The Concept of Skip Metastases. TNM staging of foregut neuro endocrine tumors: Comparison of efficacy and search for predictive factors guiding treatment choice.

Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: Metachronous jn syndromes in patients with pancreatic neuroendocrine tumors: Eur J Surg Oncol. Are they really heterogeneous? Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.

New treatment strategies in advanced neuroendocrine tumours. Ne pas utiliser si: Chromosomal alterations and germline inositol polyphosphate multikinase sequencing.


O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors.

Copy of CAT devant une péritonite by Ismail Chafik on Prezi

WHO classification of neoplasms of the neuroendocrine pancreas. Bilan initial et surveillance: Review and Position Statement. J Clin Endocrinol Metab. Il faut y associer la classification pTNM. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. Efficacy and tolerability of pegylated IFN-alpha in patients with neuroendocrine gastroenteropancreatic carcinomas. La classification OMS des TNE digestives ne prenait defant en compte ces tumeurs, mais la nouvelle classification les inclut annexe 1.

N Engl J Med. Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy. Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors.

Feasibility and efficacy of combined cisplatin and irinotecan chemotherapy for poorly differentiated neuroendocrine carcinomas. Cancer Jan 15; 2: Diagnosis and Prognostic Stratification.

Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms. Dig Liver Dis ; International histological classification of tumours. Examens morphologiques initiaux Intervention in gastro-enteropancreatic neuroendocrine tumours. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.

TNE de sites rares ou inhabituels 2. Ki index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas. Updating the surgical management of peritoneal carcinomatosis in patients with neuroendocrine tumors.


Br J Cancer ; Am J Gastroenterol ; Updating the management of patients with rectal neuroendocrine tumors. Indications du traitement antitumoral non chirurgical: Everolimus for advanced pancreatic neuroendocrine tumors.

11. Tumeurs neuroendocrines digestives (Dernière mise à jour le 12/10/2017)

J Clin Oncol ;33 suppl: TNM staging of midgut and hindgut neuro endocrine tumors: Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. Detection of liver metastases from endocrine tumors: Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a.

Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia. Histological typing of endocrine tumours. Expert Rev Anticancer Ther.

New treatment options with cytotoxic agents in neuroendocrine tumours. Clin Cancer Res ; Antonodimitrakis P et al. O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: